XOMA Corporation (XOMA)
NASDAQ: XOMA · IEX Real-Time Price · USD
28.06
+0.65 (2.37%)
At close: Jul 19, 2024, 4:30 PM
28.10
+0.04 (0.14%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
XOMA Corporation Revenue
XOMA Corporation had revenue of $5.81M in the twelve months ending March 31, 2024, with 73.10% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.49M with 240.96% year-over-year growth. In the year 2023, XOMA Corporation had annual revenue of $4.76M.
Revenue (ttm)
$5.81M
Revenue Growth
+73.10%
P/S Ratio
56.20
Revenue / Employee
$447,000
Employees
13
Market Cap
326.58M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.76M | -1.27M | -21.06% |
Dec 31, 2022 | 6.03M | -32.13M | -84.21% |
Dec 31, 2021 | 38.16M | 8.78M | 29.86% |
Dec 31, 2020 | 29.39M | 11.02M | 59.96% |
Dec 31, 2019 | 18.37M | 13.07M | 246.67% |
Dec 31, 2018 | 5.30M | -47.39M | -89.94% |
Dec 31, 2017 | 52.69M | 47.13M | 846.98% |
Dec 31, 2016 | 5.56M | -49.88M | -89.97% |
Dec 31, 2015 | 55.45M | 36.58M | 193.90% |
Dec 31, 2014 | 18.87M | -16.59M | -46.78% |
Dec 31, 2013 | 35.45M | 1.67M | 4.94% |
Dec 31, 2012 | 33.78M | -24.41M | -41.95% |
Dec 31, 2011 | 58.20M | 24.56M | 72.99% |
Dec 31, 2010 | 33.64M | -64.79M | -65.82% |
Dec 31, 2009 | 98.43M | 30.44M | 44.78% |
Dec 31, 2008 | 67.99M | -16.27M | -19.31% |
Dec 31, 2007 | 84.25M | 54.75M | 185.62% |
Dec 31, 2006 | 29.50M | 10.83M | 58.01% |
Dec 31, 2005 | 18.67M | 15.00M | 409.39% |
Dec 31, 2004 | 3.67M | -20.75M | -84.99% |
Dec 31, 2003 | 24.41M | -5.54M | -18.49% |
Dec 31, 2002 | 29.95M | 12.67M | 73.33% |
Dec 31, 2001 | 17.28M | 10.62M | 159.48% |
Dec 31, 2000 | 6.66M | 4.30M | 182.04% |
Dec 31, 1999 | 2.36M | -3.98M | -62.79% |
Dec 31, 1998 | 6.35M | -12.04M | -65.48% |
Dec 31, 1997 | 18.38M | 14.78M | 410.07% |
Dec 31, 1996 | 3.60M | 2.44M | 209.36% |
Dec 31, 1995 | 1.17M | -564.00K | -32.62% |
Dec 31, 1994 | 1.73M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nevro | 430.75M |
Amarin Corporation | 277.46M |
Zynex | 188.68M |
Kamada | 149.55M |
Spok Holdings | 140.75M |
ADC Therapeutics | 68.62M |
Foghorn Therapeutics | 33.90M |
XOMA News
- 4 weeks ago - XOMA Declares Quarterly Preferred Stock Dividends - GlobeNewsWire
- 5 weeks ago - XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals' Sale of its Priority Review Voucher - GlobeNewsWire
- 6 weeks ago - LadRx and ImmunityBio Mutually Agree to Terminate Aldoxorubicin License - Business Wire
- 2 months ago - XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ - GlobeNewsWire
- 2 months ago - XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities - GlobeNewsWire
- 3 months ago - XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One's OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) - GlobeNewsWire
- 3 months ago - Actym Therapeutics Appoints Thomas Smart as CEO - PRNewsWire
- 3 months ago - XOMA Corporation Announces Closing of Tender Offer - GlobeNewsWire